{"id":"vaginal-micronized-progesterone","safety":{"commonSideEffects":[{"rate":null,"effect":"Vaginal irritation or discharge"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Bloating"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Progesterone is a steroid hormone that acts on nuclear progesterone receptors in the endometrium and reproductive tract to promote secretory changes, suppress uterine contractions, and support implantation and early pregnancy maintenance. Micronization increases bioavailability and vaginal absorption, allowing direct delivery to reproductive tissues while minimizing systemic metabolism.","oneSentence":"Micronized progesterone administered vaginally binds to progesterone receptors to support luteal phase function and maintain early pregnancy.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:39:05.702Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Luteal phase support in assisted reproductive technology (ART)"},{"name":"Early pregnancy support and miscarriage prevention"}]},"trialDetails":[{"nctId":"NCT07496294","phase":"NA","title":"Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-04","conditions":"Menopausal Women, Menopausal Symptom Relief, Hormone Therapy","enrollment":200},{"nctId":"NCT06851754","phase":"PHASE3","title":"Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2025-07-17","conditions":"Premature Ovarian Insufficiency","enrollment":185},{"nctId":"NCT07466199","phase":"PHASE4","title":"Exogenous Progesterone as Ovulation Trigger","status":"NOT_YET_RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2026-04","conditions":"Ovulation, Ovarian Function, Assisted Reproductive Treatments","enrollment":10},{"nctId":"NCT02518594","phase":"PHASE3","title":"A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2015-11-13","conditions":"Short Cervical Length","enrollment":1311},{"nctId":"NCT07461909","phase":"","title":"Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2024-11-08","conditions":"Frozen Embryo Transfer (FET), Infertility, Artificial Cycle","enrollment":400},{"nctId":"NCT02913495","phase":"PHASE4","title":"Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2016-09","conditions":"Premature Birth","enrollment":210},{"nctId":"NCT06307184","phase":"","title":"Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2024-02-23","conditions":"Frozen Embryo Transfer","enrollment":530},{"nctId":"NCT07372495","phase":"NA","title":"Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix","status":"NOT_YET_RECRUITING","sponsor":"National Hospital of Obstetrics and Gynecology","startDate":"2026-03-01","conditions":"Preterm","enrollment":260},{"nctId":"NCT04499131","phase":"PHASE4","title":"Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2021-12-09","conditions":"Infertility, Female, ENDOMETRIAL RECEPTIVITY","enrollment":109},{"nctId":"NCT06372119","phase":"NA","title":"Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-22","conditions":"Embryo Transfer, Irregular Menstruation, Letrozole","enrollment":790},{"nctId":"NCT06975943","phase":"NA","title":"Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Soetomo General Hospital","startDate":"2024-01-01","conditions":"Pregnant Women, Pregnancies at Increased Risk of Preterm Birth","enrollment":48},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT05473273","phase":"","title":"Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2023-04-24","conditions":"Infertility, Female","enrollment":40},{"nctId":"NCT03976544","phase":"PHASE4","title":"Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients","status":"TERMINATED","sponsor":"CRG UZ Brussel","startDate":"2019-05-25","conditions":"Miscarriage, Frozen Embryo Transfer, Natural Cycle","enrollment":362},{"nctId":"NCT04301518","phase":"NA","title":"Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sera Prognostics, Inc.","startDate":"2020-11-06","conditions":"Preterm Labor, Preterm Birth","enrollment":6500},{"nctId":"NCT06644794","phase":"PHASE3","title":"Progesterone-modified Natural Cycle for FET","status":"NOT_YET_RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2024-12-05","conditions":"Infertility, Female","enrollment":336},{"nctId":"NCT06616077","phase":"EARLY_PHASE1","title":"Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone","status":"COMPLETED","sponsor":"Reproductive Health Research Insritute, Chile","startDate":"2022-06-07","conditions":"Endometrial Endocrine Regulation, Progesterone Supplementation in Women After Mifepristone","enrollment":9},{"nctId":"NCT05899010","phase":"PHASE3","title":"MIcronized PROgesterone in Frozen Embryo Transfer Cycles","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-07-05","conditions":"Infertility","enrollment":1020},{"nctId":"NCT04758871","phase":"PHASE4","title":"Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2021-10-01","conditions":"Frozen Embryo Transfer, Hormone Replacement Therapy, Dydrogesterone","enrollment":150},{"nctId":"NCT04092829","phase":"NA","title":"Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer","status":"TERMINATED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2019-09-16","conditions":"Pre-Eclampsia, Frozen Embryo Transfer","enrollment":591},{"nctId":"NCT02460302","phase":"PHASE2","title":"Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy","status":"WITHDRAWN","sponsor":"Mount Sinai Hospital, Canada","startDate":"2016-12","conditions":"Atrophic Vaginitis, Menopause, Vulvovaginal Atrophy","enrollment":""},{"nctId":"NCT05168865","phase":"PHASE4","title":"Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.","status":"WITHDRAWN","sponsor":"Dubai Fertility Center","startDate":"2023-08-01","conditions":"Frozen Embryo Transfer, Polycystic Ovarian Disease, Letrozole","enrollment":""},{"nctId":"NCT05997563","phase":"PHASE4","title":"Adjunctive Vaginal Progesterone in Management of Preterm Labor","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2023-08-16","conditions":"Preterm Labor","enrollment":48},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":"Infertility","enrollment":120},{"nctId":"NCT02430233","phase":"PHASE4","title":"Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2018-12-19","conditions":"Preterm Labor","enrollment":129},{"nctId":"NCT03803228","phase":"PHASE3","title":"Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2018-09-03","conditions":"Fertility Disorders","enrollment":88},{"nctId":"NCT01406197","phase":"NA","title":"Uterine Electrical Activity Before and After Progesterone Treatment for Preterm Labor","status":"WITHDRAWN","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2011-07","conditions":"Preterm Labor","enrollment":""},{"nctId":"NCT05484193","phase":"NA","title":"GnRH Agonist for Luteal Phase Support.","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2020-06-08","conditions":"Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles","enrollment":150},{"nctId":"NCT04753957","phase":"PHASE1","title":"Pharmacokinetics of Progesterone in Pregnancy-2","status":"TERMINATED","sponsor":"Thomas Jefferson University","startDate":"2022-01-07","conditions":"Pregnancy Related","enrollment":3},{"nctId":"NCT03734770","phase":"NA","title":"Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support","status":"COMPLETED","sponsor":"Universita di Verona","startDate":"2019-01-01","conditions":"Progesterone, Luteal Phase Support, In Vitro Fertilization","enrollment":149},{"nctId":"NCT01959464","phase":"PHASE4","title":"Sexual Absorption of Vaginal Progesterone","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2008-11","conditions":"Infertility, Pregnancy","enrollment":20},{"nctId":"NCT04722471","phase":"","title":"Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2021-03-03","conditions":"Luteal Phase Defect","enrollment":347},{"nctId":"NCT04002635","phase":"PHASE4","title":"Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)","status":"WITHDRAWN","sponsor":"CRG UZ Brussel","startDate":"2020-12-01","conditions":"Infertility, Female, Polycystic Ovary Syndrome, IVF","enrollment":""},{"nctId":"NCT03677336","phase":"PHASE4","title":"Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2019-05-01","conditions":"Infertility, Female, Infertility, Genital Diseases, Male","enrollment":30},{"nctId":"NCT03992937","phase":"NA","title":"Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2019-06-20","conditions":"Endometrial Hyperplasia Without Atypia","enrollment":132},{"nctId":"NCT03565211","phase":"PHASE3","title":"Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-07-26","conditions":"Progesterone Supplementation in Women Undergoing ART","enrollment":352},{"nctId":"NCT03832699","phase":"NA","title":"Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer","status":"UNKNOWN","sponsor":"Wolfson Medical Center","startDate":"2019-03-01","conditions":"ART","enrollment":100},{"nctId":"NCT03740568","phase":"NA","title":"Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes.","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2018-11-15","conditions":"Infertility, Progesterone, Frozen Embryo Transfer","enrollment":598},{"nctId":"NCT04453332","phase":"NA","title":"Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2015-10-09","conditions":"Menopause, Hormone Replacement Therapy","enrollment":60},{"nctId":"NCT03340701","phase":"PHASE1","title":"Pharmacokinetics of Progesterone in Pregnancy","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2017-11-06","conditions":"Progesterone","enrollment":6},{"nctId":"NCT02970552","phase":"PHASE4","title":"Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-07-01","conditions":"PreTerm Birth","enrollment":140},{"nctId":"NCT03181685","phase":"PHASE4","title":"Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles","status":"TERMINATED","sponsor":"Andros Day Surgery Clinic","startDate":"2016-12-20","conditions":"Infertility, In Vitro Fertilization","enrollment":60},{"nctId":"NCT04124913","phase":"PHASE4","title":"Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Memorial Sisli Hospital, Istanbul","startDate":"2019-01-02","conditions":"Infertility, Female, Infertility, Male, Embryo Transfer","enrollment":140},{"nctId":"NCT02772120","phase":"PHASE4","title":"Comparison of Vaginal and Intramuscular Progesterone in Vitrified-warmed Blastocyst Transfer Cycles","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"","conditions":"Infertility","enrollment":""},{"nctId":"NCT03938064","phase":"PHASE4","title":"Timing of Initiation of Luteal Phase Support in Poor Responders Undergoing IVF/ICSI","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2019-06-26","conditions":"Infertility","enrollment":520},{"nctId":"NCT01840228","phase":"NA","title":"Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2013-05","conditions":"Premature Birth, Obstetric Labor, Premature","enrollment":38},{"nctId":"NCT02254577","phase":"PHASE4","title":"Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Shady Grove Fertility Reproductive Science Center","startDate":"2014-10","conditions":"Infertility","enrollment":1139},{"nctId":"NCT01269450","phase":"NA","title":"Progesterone and Second Trimester Bleeding","status":"TERMINATED","sponsor":"HaEmek Medical Center, Israel","startDate":"2011-03","conditions":"Antepartum Bleeding, Preterm Birth","enrollment":128},{"nctId":"NCT02989519","phase":"PHASE3","title":"Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor","status":"COMPLETED","sponsor":"Sanpasitthiprasong Hospital","startDate":"2015-08","conditions":"Preterm Delivery","enrollment":231},{"nctId":"NCT03267771","phase":"PHASE4","title":"Progesterone and Doppler in Recurrent Abortion","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-10-01","conditions":"Abortion in First Trimester","enrollment":50},{"nctId":"NCT02329535","phase":"NA","title":"Comparing Double Dose of Vaginal Progesterone to no Treatment for Prevention of Preterm Birth in Twins and Short Cervix","status":"TERMINATED","sponsor":"HaEmek Medical Center, Israel","startDate":"2015-01","conditions":"Premature Birth","enrollment":15},{"nctId":"NCT02118051","phase":"PHASE3","title":"Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2013-09","conditions":"Infertility","enrollment":234},{"nctId":"NCT03088046","phase":"NA","title":"Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2014-02","conditions":"Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism","enrollment":15},{"nctId":"NCT03058536","phase":"PHASE2, PHASE3","title":"Progesterone and Cervical Pessary in Twins","status":"UNKNOWN","sponsor":"Mario Henrique Burlacchini de Carvalho","startDate":"2017-02-21","conditions":"Preterm Birth, Twin Pregnancy With Antenatal Problem","enrollment":312},{"nctId":"NCT01500863","phase":"PHASE4","title":"Endometrial Receptivity After GnRH Agonist Triggering","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2011-11","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":35},{"nctId":"NCT01643980","phase":"PHASE4","title":"Prevention of Preterm Birth in Pregnant Women at Risk Identified by Ultrasound: Evaluation of Two Treatment Strategies","status":"COMPLETED","sponsor":"Dra.Cristina Martinez Payo","startDate":"2012-08","conditions":"Early Onset of Delivery Before 37 Weeks","enrollment":254},{"nctId":"NCT01178788","phase":"PHASE3","title":"Progestagens for the Tertiary Prophylaxis of Preterm Delivery","status":"COMPLETED","sponsor":"University of Modena and Reggio Emilia","startDate":"2010-02","conditions":"Preterm Delivery, Neonatal Complications","enrollment":254},{"nctId":"NCT02690129","phase":"NA","title":"Vaginal Progesterone for Treatment of Threatened Miscarriage","status":"UNKNOWN","sponsor":"Omar Mamdouh Shaaban","startDate":"2016-02","conditions":"Threatened Miscarriage","enrollment":290},{"nctId":"NCT01523483","phase":"NA","title":"Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm Labor","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2012-03","conditions":"Preterm Birth","enrollment":30},{"nctId":"NCT02304237","phase":"PHASE3","title":"Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women","status":"UNKNOWN","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2014-12","conditions":"Premature Birth","enrollment":360},{"nctId":"NCT01432028","phase":"NA","title":"Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women","status":"COMPLETED","sponsor":"Denusa Wiltgen","startDate":"2007-03","conditions":"Postmenopause","enrollment":90},{"nctId":"NCT01353846","phase":"PHASE4","title":"Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients","status":"UNKNOWN","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2011-05","conditions":"Infertility","enrollment":70},{"nctId":"NCT00247169","phase":"PHASE2","title":"Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2004-08","conditions":"Cervical Intraepithelial Neoplasia","enrollment":40},{"nctId":"NCT01465373","phase":"PHASE4","title":"Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs","status":"COMPLETED","sponsor":"Fertility Centers of Illinois","startDate":"2010-02","conditions":"Infertility","enrollment":10},{"nctId":"NCT00656201","phase":"PHASE4","title":"Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2003-07","conditions":"Infertility","enrollment":468},{"nctId":"NCT00296478","phase":"PHASE3","title":"Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2005-07","conditions":"Fertility","enrollment":1211}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":87,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cyclogest® 400 mg"],"phase":"marketed","status":"active","brandName":"Vaginal micronized progesterone","genericName":"Vaginal micronized progesterone","companyName":"Instituto Valenciano de Infertilidade de Lisboa","companyId":"instituto-valenciano-de-infertilidade-de-lisboa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Micronized progesterone administered vaginally binds to progesterone receptors to support luteal phase function and maintain early pregnancy. Used for Luteal phase support in assisted reproductive technology (ART), Early pregnancy support and miscarriage prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}